Matthew R. Henn - Net Worth and Insider Trading
Matthew R. Henn Net Worth
The estimated net worth of Matthew R. Henn is at least $73,586 dollars as of 2024-05-05. Matthew R. Henn is the See Remarks of Seres Therapeutics Inc and owns about 63,436 shares of Seres Therapeutics Inc (MCRB) stock worth over $73,586. Details can be seen in Matthew R. Henn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew R. Henn has not made any transactions after 2024-02-16 and currently still holds the listed stock(s).
Transaction Summary of Matthew R. Henn
Matthew R. Henn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew R. Henn owns 1 companies in total, including Seres Therapeutics Inc (MCRB) .
Click here to see the complete history of Matthew R. Henn’s form 4 insider trades.
Insider Ownership Summary of Matthew R. Henn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-02-16 | Chief Scientific Officer |
Matthew R. Henn Latest Holdings Summary
Matthew R. Henn currently owns a total of 1 stock. Matthew R. Henn owns 63,436 shares of Seres Therapeutics Inc (MCRB) as of February 16, 2024, with a value of $73,586.
Latest Holdings of Matthew R. Henn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-02-16 | 63,436 | 1.16 | 73,586 |
Holding Weightings of Matthew R. Henn
Matthew R. Henn Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew R. Henn has made a total of 3 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Seres Therapeutics Inc is the sale of 4,170 shares on February 16, 2024, which brought Matthew R. Henn around $4,504.
Insider Trading History of Matthew R. Henn
- 1
Matthew R. Henn Trading Performance
Matthew R. Henn Ownership Network
Matthew R. Henn Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
Matthew R. Henn is the Chief Scientific Officer of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include CFO and EVP Eric D. Shaff , Chief Financial Officer David Arkowitz , and See Remarks Thomas Desrosier .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, Matthew R. Henn made 2 insider transaction in Seres Therapeutics Inc (MCRB) with a net sale of 8,056. Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 16,114 shares made by David S. Ege , a net sale of 20,101 shares made by Eric D. Shaff , and a net sale of 8,632 shares made by Moltke Lisa Von .
In summary, during the past 3 months, insiders sold 36,381 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 36,381 shares. During the past 18 months, 78,188 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,188 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
Matthew R. Henn Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew R. Henn. You might contact Matthew R. Henn via mailing address: C/o Seres Therapeutics, Inc., 200 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
